ALTO-100 in MDD and/or PTSD

Status:
Not yet recruiting

Trial end date:
2023-07-01

Target enrollment:

Participant gender:

The goal of this study is to collect biologically based data for defining predictors and correlates of the effects of ALTO-100.

Phase 2

Alto Neuroscience